Gilead Sciences Inc.
GILD | NASDAQ
$150.56
+$0.45 (+0.30%)
At close: Sep 21, 2026, 4:00 PM ET
$149
-$1.56 (-1.04%)
After-hours:
Sep 21, 2026, 7:57 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 17.94 | 243.08 | 17.84 | 23.46 | 14.64 | 595.10 |
PEG Ratio | 0.01 | -2.65 | 0.74 | -0.89 | 0 | -6.09 |
PS Ratio | 5.19 | 4.01 | 3.73 | 3.95 | 3.34 | 2.97 |
PB Ratio | 6.73 | 5.96 | 4.43 | 5.07 | 4.33 | 4.02 |
P/FCF Ratio | 16.15 | 11.18 | 13.62 | 12.91 | 8.44 | 9.74 |
P/OCF Ratio | 15.24 | 10.64 | 12.63 | 11.88 | 8.01 | 8.97 |
OCF/S Ratio | 34.03 | 37.66 | 29.52 | 33.25 | 41.69 | 33.08 |
Debt / Equity Ratio | 1.10 | 1.38 | 1.09 | 1.19 | 1.27 | 1.73 |
Quick Ratio | 1.40 | 1.45 | 1.27 | 1.15 | 1.13 | 1.26 |
Current Ratio | 1.55 | 1.60 | 1.43 | 1.29 | 1.27 | 1.40 |
Asset Turnover | 0.50 | 0.49 | 0.44 | 0.43 | 0.40 | 0.36 |
Interest Coverage | 11.43 | 1.70 | 8.06 | 7.84 | 9.91 | 4.14 |
Return on Equity | 37.49% | 2.48% | 24.81% | 21.62% | 29.55% | 0.68% |
Return on Assets | 14.42% | 0.81% | 9.12% | 7.27% | 9.16% | 0.18% |
Return on Invested Capital | 20.32% | 2.36% | 11.82% | 10.62% | 12.84% | 0.36% |
Dividend Yield | 2.62% | 3.40% | 3.77% | 3.44% | 3.95% | 4.71% |
Payout Ratio | 47.04% | 816.25% | 67.24% | 80.77% | 57.91% | 2.8K% |
FCF Payout Ratio | 46.75% | 41.37% | 57.24% | 48.17% | 35.45% | 50.17% |
Gross Profit Margin | 78.83% | 78.26% | 76.04% | 79.26% | 75.82% | 81.48% |
Net Profit Margin | 28.90% | 1.67% | 20.89% | 16.83% | 22.80% | 0.50% |
Pretax Profit Margin | 33.27% | 2.40% | 25.30% | 21.31% | 30.32% | 6.76% |
Operating Profit Margin | 39.74% | 5.78% | 28.05% | 26.87% | 36.32% | 16.49% |
FCF Margin | 32.12% | 35.84% | 27.37% | 30.59% | 39.57% | 30.45% |
EBITDA Margin | 46.12% | 15.42% | 38.71% | 32.45% | 41.49% | 16.74% |
Add to Watchlist
Select watchlists to add or remove GILD